Clinical Trials
5 trialsNCT05859334 2026-05-13
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05316155 2026-05-08
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Janssen Research & Development, LLC
Phase 1/2 Recruiting
NCT06319820 2026-05-08
MoonRISe-1
Janssen Research & Development, LLC
Phase 3 Recruiting
NCT06919965 2026-05-08
MoonRISe-3
Janssen Research & Development, LLC
Phase 3 Recruiting
NCT02925234 2024-01-24
DRUP
The Netherlands Cancer Institute
Phase 2 Recruiting